S-Nitrosoglutathione Acts as a Small Molecule Modulator of Human Fibrin Clot Architecture

Abstract

BackgroundAltered fibrin clot architecture is increasingly associated with cardiovascular diseases; yet, little is known about how fibrin networks are affected by small molecules that alter fibrinogen structure. Based on previous evidence that S-nitrosoglutathione (GSNO) alters fibrinogen secondary structure and fibrin polymerization kinetics, we hypothesized that GSNO would alter fibrin microstructure.Methodology/Principal FindingsAccordingly, we treated human platelet-poor plasma with GSNO (0.01–3.75 mM) and imaged thrombin induced fibrin networks using multiphoton microscopy. Using custom designed computer software, we analyzed fibrin microstructure for changes in structural features including fiber density, diameter, branch point density, crossing fibers and void area. We report for the first time that GSNO dose-dependently decreased fibrin density until complete network inhibition was achieved. At low dose GSNO, fiber diameter increased 25%, maintaining clot void volume at approximately 70%. However, at high dose GSNO, abnormal irregularly shaped fibrin clusters with high fluorescence intensity cores were detected and clot void volume increased dramatically. Notwithstanding fibrin clusters, the clot remained stable, as fiber branching was insensitive to GSNO and there was no evidence of fiber motion within the network. Moreover, at the highest GSNO dose tested, we observed for the first time, that GSNO induced formation of fibrin agglomerates.Conclusions/SignificanceTaken together, low dose GSNO modulated fibrin microstructure generating coarse fibrin networks with thicker fibers; however, higher doses of GSNO induced abnormal fibrin structures and fibrin agglomerates. Since GSNO maintained clot void volume, while altering fiber diameter it suggests that GSNO may modulate the remodeling or inhibition of fibrin networks over an optimal concentration range.

Hyperinsulinemia does not cause de novo capillary recruitment in rat skeletal muscle

“…They demonstrated that contraction of the muscle resulted in a tenfold increase in RBC velocity without an increase in perfused capillary density . Although our preparation of the EDL for transillumination requires tying a suture around the distal tendon and cutting the tendon between the suture and its attachment, the muscle maintains a stable microvascular perfusion with resting RBC velocities for up to 5‐6 hours similar to those reported by Tyml . Two independent research groups have also shown that exteriorization does not alter muscle flow .…”

Functional impact of oxidative posttranslational modifications on fibrinogen and fibrin clots

“…Additional studies have investigated the role of GSNO treatment on fibrin clot structure. Fiber density decreased and fiber diameter increased following GSNO treatment of PPP [82]. …”

Characterisation and the effects of bilirubin binding to human fibrinogen

“…Fibrinogen interacts with tissue factors and cytokines, such as fibroblast growth factor-2, vascular endothelial growth factor and interleukin-1β [3]. Hyaluronic acid and S-nitrosoglutathione are able to bind to fibrinogen and fibrin causing modulation of their functions [5,6].…”